85.37
전일 마감가:
$86.94
열려 있는:
$86.49
하루 거래량:
1.08M
Relative Volume:
1.19
시가총액:
$7.29B
수익:
$1.15B
순이익/손실:
$96.70M
주가수익비율:
78.32
EPS:
1.09
순현금흐름:
$-161.99M
1주 성능:
-9.33%
1개월 성능:
-11.07%
6개월 성능:
-12.59%
1년 성능:
-14.71%
Healthequity Inc Stock (HQY) Company Profile
명칭
Healthequity Inc
전화
801-727-1000
주소
15 WEST SCENIC POINTE DRIVE, DRAPER, UT
HQY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
HQY
Healthequity Inc
|
85.37 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
VEEV
Veeva Systems Inc
|
222.21 | 35.99B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.33 | 12.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
41.26 | 7.73B | 550.17M | 201.35M | 232.07M | 1.00 |
|
BTSG
Brightspring Health Services Inc
|
39.20 | 7.14B | 11.99B | 24.18M | 234.31M | 0.2956 |
Healthequity Inc Stock (HQY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-05-22 | 재개 | RBC Capital Mkts | Outperform |
| 2025-03-25 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-12-04 | 개시 | Mizuho | Outperform |
| 2024-11-15 | 개시 | Goldman | Neutral |
| 2024-04-04 | 개시 | JMP Securities | Mkt Outperform |
| 2024-04-02 | 재확인 | JP Morgan | Overweight |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-09-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-10-21 | 업그레이드 | Goldman | Sell → Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-07-12 | 개시 | Goldman | Sell |
| 2022-04-11 | 개시 | Wells Fargo | Overweight |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-03-30 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2021-12-07 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-09-09 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2021-07-02 | 개시 | Stephens | Overweight |
| 2021-04-29 | 재개 | JP Morgan | Overweight |
| 2021-01-07 | 개시 | BTIG Research | Neutral |
| 2020-12-08 | 재확인 | Barrington Research | Outperform |
| 2020-12-02 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-23 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-10-23 | 개시 | RBC Capital Mkts | Outperform |
| 2020-04-14 | 개시 | Guggenheim | Buy |
| 2020-04-13 | 개시 | SVB Leerink | Mkt Perform |
| 2020-03-17 | 재확인 | Barrington Research | Outperform |
| 2019-10-07 | 개시 | Goldman | Neutral |
| 2019-09-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2019-07-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-06-05 | 재확인 | BofA/Merrill | Neutral |
| 2019-03-01 | 재확인 | BofA/Merrill | Neutral |
| 2019-02-07 | 재확인 | Chardan Capital Markets | Buy |
| 2019-02-07 | 업그레이드 | SunTrust | Hold → Buy |
| 2018-12-06 | 다운그레이드 | SunTrust | Buy → Hold |
| 2018-09-06 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-05-23 | 개시 | BofA/Merrill | Buy |
| 2018-04-24 | 재개 | JP Morgan | Overweight |
| 2018-03-20 | 재확인 | Chardan Capital Markets | Buy |
| 2017-12-06 | 재확인 | Chardan Capital Markets | Buy |
모두보기
Healthequity Inc 주식(HQY)의 최신 뉴스
Stephens Investment Management Group LLC Has $68.64 Million Stock Holdings in HealthEquity, Inc. $HQY - MarketBeat
New York Gov. Hochul Reveals Cannabis Initiatives Aimed at Supply Chain, Health Equity - Cannabis Equipment News
HealthEquity, Inc. (NASDAQ:HQY) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
The Market's Not Diagnosing HealthEquity Accurately (NASDAQ:HQY) - Seeking Alpha
HQYHealthEquity Announces Closing of Follow-on Offering - ADVFN
A Look At HealthEquity (HQY) Valuation As New Guidance And Split Analyst Calls Draw Attention - Sahm
HealthEquity Announces Year-End Sales Outlook, Presentation at JP Morgan Healthcare Conference - ADVFN
HealthEquity (NASDAQ:HQY) Trading Down 6.5%Here's Why - MarketBeat
HealthEquity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2027 - marketscreener.com
HealthEquity expects FY 2027 revenue between $1.38B and $1.41B; shares down over 7% - MSN
HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test - TechStock²
HealthEquity drops after 2027 outlook misses estimates - TradingView — Track All Markets
Why Is HealthEquity’s Hot Streak Suddenly Faltering? - TipRanks
HealthEquity sees FY27 revenue $1.38B-$1.41B, consensus $1.41B - TipRanks
HealthEquity Expects Fiscal 2027 Revenue of $1.38 Billion to $1.41 Billion - marketscreener.com
HealthEquity Issues Confident Fiscal 2027 Outlook and Guidance - TipRanks
HealthEquity, Inc. Projects Fiscal Year 2027 Revenue Range and Reaffirms Fiscal Year 2026 Guidance - Quiver Quantitative
HealthEquity Announces Fiscal Year 2027 Outlook Presentation at J.P. Morgan Healthcare Conference - The Manila Times
Healthequity announces fiscal year 2027 outlook presentation at J.P. Morgan healthcare conference - marketscreener.com
Healthequity Announces Fiscal Year 2027 Outlook Presentation At J.P. Morgan Healthcare Conference - TradingView — Track All Markets
Summit Creek Advisors LLC Sells 15,670 Shares of HealthEquity, Inc. $HQY - MarketBeat
Habilitative Systems, Inc. Honors Education Leaders at 5th Annual Race & Health Equity Awards - 24-7 Press Release Newswire
(HQY) and the Role of Price-Sensitive Allocations - Stock Traders Daily
HealthEquity (NASDAQ:HQY) delivers shareholders decent 16% CAGR over 3 years, surging 3.4% in the last week alone - Yahoo Finance
HealthEquity (NASDAQ:HQY) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Did Goldman's HQY Downgrade Amid Bullish Peers Just Reframe HealthEquity's Valuation Debate? - Sahm
Reasons to Add HealthEquity Stock to Your Portfolio for Now - MSN
HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March - TechStock²
HealthEquity (NASDAQ:HQY) Shares Gap DownShould You Sell? - MarketBeat
Why Healthequity’s Stock Is Struggling Despite Strong Results - TipRanks
Goldman Sachs Downgrades HealthEquity (HQY) to 'Sell' | HQY Stoc - GuruFocus
What 8 Analyst Ratings Have To Say About HealthEquity - Benzinga
Goldman Sachs Downgrades HealthEquity to Sell From Neutral, Adjusts Price Target to $89 From $113 - marketscreener.com
HealthEquity downgraded to Sell from Neutral at Goldman Sachs - TipRanks
HealthEquity Shares Fall After Goldman Sachs Downgrade - marketscreener.com
Will HealthEquity Inc. stock keep outperforming rivalsMarket Activity Report & Technical Confirmation Alerts - ulpravda.ru
HealthEquity (HQY): Keybanc Raises Price Target to $125.00 | HQY Stock News - GuruFocus
HealthEquity price target raised to $125 from $120 at KeyBanc - TipRanks
Healthequity (HQY) Gets a Buy from J.P. Morgan - The Globe and Mail
Can HealthEquity Inc. stock surprise with earnings upsideResistance Breakout Alerts & Explosive Growth Trading - ulpravda.ru
MarketsMedicine Hat NewsMedicine Hat NewsHealthEquity, Inc.Common Stock (Nasdaq:HQY) Price Chart - FinancialContent
Will HealthEquity Inc. stock recover faster than peers2026 world cup usa national team group stage defensive leaders transition play winner prediction analysis - Улправда
Is HealthEquity Inc 2HE a good long term investmentDividend Stability Analysis & Stocks With 200% Upside Potential - earlytimes.in
Investors Interested In HealthEquity, Inc.'s (NASDAQ:HQY) Earnings - 富途牛牛
Gear Up for HealthEquity (HQY) Q4 Earnings: Wall Street Estimates for Key Metrics - MSN
HealthEquity (FRA:2HE) EV-to-OCF : 20.00 (As of Jan. 03, 2026) - GuruFocus
HealthEquity (NASDAQ:HQY) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Tectonic Advisors LLC Grows Stake in HealthEquity, Inc. $HQY - MarketBeat
Pacer Advisors Inc. Purchases Shares of 11,490 HealthEquity, Inc. $HQY - MarketBeat
Econ Financial Services Corp Makes New Investment in HealthEquity, Inc. $HQY - MarketBeat
HealthEquity, Inc. $HQY Position Cut by Moody Aldrich Partners LLC - MarketBeat
Healthequity Inc (HQY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):